Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongshan Kangfang Biopharma
Zhongshan, Guangdong Sheng, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Zhongshan Kangfang Biopharma operates as a subsidiary or affiliate of Akeso. The group has developed a robust pipeline with over fifty innovative drug candidates spanning monoclonal and bispecific antibodies, ADCs, mRNA therapies and cell therapies. Several assets have reached pivotal Phase III trials or commercialization—most notably penpulimab-kcqx for advanced nasopharyngeal carcinoma received FDA approval in April 2025. The company’s integrated R&D platform supports end-to-end drug development from discovery through manufacturing and commercialization.
- Therapeutic areas
- ImmunologyMetabolic DisordersOncology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugatemRNA-based drugsCell therapy
- Industry
- Biotech
02
Partnerships
Beyond the preview
Go deeper on Zhongshan Kangfang Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhongshan Kangfang Biopharma.